Bordetella pertussis Antibodies, IgA, IgG, and IgM by Immunoblot

Casandra

Casandra Test Code AR55726Version 1 (DRAFT)

Performing Lab

Lab ARUP LaboratoriesLab Test ID 2004328CPT Code 86615

Bordetella pertussis Antibodies, IgA, IgG, and IgM by Immunoblot

Also known as: BORD BLOTS

Clinical Use

Order Test

Use

This test is used to detect and differentiate antibodies (IgA, IgG, and IgM) against Bordetella pertussis, which is the causative agent of whooping cough. Detection of these antibodies is useful for diagnosing recent or previous infections or for assessing vaccination status, particularly in late-stage pertussis cases (>4 weeks). This test is particularly useful when PCR or culture results are negative and there is a high suspicion of pertussis.

Special Instructions

For late-stage pertussis serological assessment, this test is recommended. Samples from New York clients will be sent to a New York state-approved lab due to non-approval for local processing.

Limitations

This test is not cleared or approved by the FDA and should not be used as the sole basis for diagnosing or ruling out disease. The performance characteristics of this test were determined by ARUP Laboratories, and it is performed in a CLIA-certified laboratory. Interpretive caution is advised as the presence of antibodies can also indicate recent vaccination rather than active infection.

Test Details